Trial Profile

HEALEY ALS Platform Trial - Regimen B Verdiperstat

Status: Completed

Phase of Trial: Phase II/III

Latest Information Update: 13 Jun 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Verdiperstat (Primary)
Indications Amyotrophic lateral sclerosis
Focus Therapeutic Use

Most Recent Events

15 May 2023 Status changed from active, no longer recruiting to completed.
29 Sep 2022 According to a Biohaven Pharmaceutical Holding Company Media Release, additional analyses are ongoing, and complete study results will be presented at an upcoming scientific meeting.
29 Sep 2022 Results published in the Biohaven Pharmaceutical Holding Company Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com